Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serum.

Elefanti A, Mouton JW, Krompa K, Al-Saigh R, Verweij PE, Zerva L, Meletiadis J.

Antimicrob Agents Chemother. 2013 Apr;57(4):1625-31. doi: 10.1128/AAC.01573-12. Epub 2013 Jan 14.

2.

Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions.

Elefanti A, Mouton JW, Verweij PE, Tsakris A, Zerva L, Meletiadis J.

Antimicrob Agents Chemother. 2013 Oct;57(10):4656-63. doi: 10.1128/AAC.00597-13. Epub 2013 Jul 15.

3.

Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.

Meletiadis J, Antachopoulos C, Stergiopoulou T, Pournaras S, Roilides E, Walsh TJ.

Antimicrob Agents Chemother. 2007 Sep;51(9):3329-37. Epub 2007 Jun 18.

4.

Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.

Meletiadis J, Al-Saigh R, Velegraki A, Walsh TJ, Roilides E, Zerva L.

Antimicrob Agents Chemother. 2012 Jan;56(1):403-10. doi: 10.1128/AAC.00662-11. Epub 2011 Nov 7.

5.

Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology.

Cafini F, Sevillano D, Alou L, Gómez-Aguado F, Corcuera MT, González N, Guinea J, Prieto J.

Rev Esp Quimioter. 2012 Mar;25(1):47-55.

6.

In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.

Pfaller MA, Duncanson F, Messer SA, Moet GJ, Jones RN, Castanheira M.

Antimicrob Agents Chemother. 2011 Nov;55(11):5155-8. doi: 10.1128/AAC.00570-11. Epub 2011 Aug 15.

7.
8.

A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.

Krishnan S, Manavathu EK, Chandrasekar PH.

J Antimicrob Chemother. 2005 Jun;55(6):914-20. Epub 2005 Apr 11.

PMID:
15824093
9.

Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.

O'Shaughnessy EM, Meletiadis J, Stergiopoulou T, Demchok JP, Walsh TJ.

J Antimicrob Chemother. 2006 Dec;58(6):1168-76. Epub 2006 Oct 27.

PMID:
17071635
10.
11.

In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.

Mallié M, Bastide JM, Blancard A, Bonnin A, Bretagne S, Cambon M, Chandenier J, Chauveau V, Couprie B, Datry A, Feuilhade M, Grillot R, Guiguen C, Lavarde V, Letscher V, Linas MD, Michel A, Morin O, Paugam A, Piens MA, Raberin H, Tissot E, Toubas D, Wade A.

Int J Antimicrob Agents. 2005 Apr;25(4):321-8.

PMID:
15784312
13.
14.

[In vitro activity of amphotericin B, itraconazole and voriconazole against 20 species of Aspergillus using the Sensititre microdilution method].

García-Martos P, García-Agudo L, Gutiérrez-Calzada J, Ruiz-Aragón J, Saldarreaga A, Marín P.

Enferm Infecc Microbiol Clin. 2005 Jan;23(1):15-8. Spanish.

PMID:
15701327
17.

Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.

Chandrasekar PH, Cutright JL, Manavathu EK.

Diagn Microbiol Infect Dis. 2001 Dec;41(4):211-4.

PMID:
11777662
18.

Comparative pharmacodynamic interaction analysis of triple combinations of caspofungin and voriconazole or ravuconazole with subinhibitory concentrations of amphotericin B against Aspergillus spp.

Demchok JP, Meletiadis J, Roilides E, Walsh TJ.

Mycoses. 2010 May;53(3):239-45. doi: 10.1111/j.1439-0507.2009.01700.x. Epub 2009 Mar 7.

PMID:
19389068
19.

Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.

Öz Y, Özdemir HG, Gökbolat E, Kiraz N, Ilkit M, Seyedmousavi S.

Mycopathologia. 2016 Apr;181(3-4):225-33. doi: 10.1007/s11046-015-9969-z. Epub 2015 Nov 26.

20.

Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.

Meletiadis J, Stergiopoulou T, O'Shaughnessy EM, Peter J, Walsh TJ.

Antimicrob Agents Chemother. 2007 Jun;51(6):2053-64. Epub 2007 Mar 26.

Supplemental Content

Support Center